Clinical Research Directory
Browse clinical research sites, groups, and studies.
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
Sponsor: Centre Paul Strauss
Summary
\[18 F\]fluorodeoxyglucose (18F-FDG) positron emission tomography-magnetic resonance imaging (PET/MRI) is a new hybrid imaging tool that has recently arrived in oncology, and is particularly promising. Its usefulness seems obvious in certain tumor types, but its place in the staging of cervical cancers has never been explored in a prospective trial to our knowledge. Previously, a comparative retrospective study from 2009 found a better sensitivity of PET fused to diagnostic MRI images compared to PET/CT (positron emission tomography/computed tomography) in the detection of metastatic lymph nodes (54 and 44% respectively). It was an a posteriori fusion of images, from images acquired by PET-CT.
Official title: Contribution of PET/MRI in Locally Advanced Cervical Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-10-12
Completion Date
2026-09-11
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
18-FDG PET-MRI
For this trial, 18-FDG PET-MRI will be conducted directly after PET-CT using a single dose of radiotracer
Locations (1)
Institut de cancérologie Strasbourg Europe
Strasbourg, France